Skip to main content

Table 4 Parameter wise number of patients who scored less than the best possible grade (<BPG) at baseline and reached BPG afterwards

From: Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy

Parameters

Affected patients (<BPG)

Improved patients at end of therapy; n (%)

Appetite

7

7 (100.0)

Attention

3

3 (100.0)

Balance—eyes closed in straight line

26

1 (3.8)

Balance—eyes open in straight line

24

3 (12.5)

Bladder—control

12

2 (16.7)

Bladder—sensation

8

2 (25.0)

Bowel—control

6

1 (16.7)

Bowel—sensation

4

2 (50.0)

Breathing pattern—Brady

1

1 (100.0)

Communication—speech

4

2 (50.0)

Coordination

14

0

Deformity

8

1 (12.5)

Depression

6

4 (66.7)

Double-vision + color blindness

5

1 (20.0)

Ears—hearing

3

3 (100.0)

Eye pain

2

2 (100.0)

Fatigue

22

8 (36.4)

Floaters

2

1 (50.0)

Irritability

7

4 (57.1)

Language

3

1 (33.3)

Limb tremors

15

6 (40.0)

Memory

7

5 (71.4)

Muscle weakness

27

3 (11.1)

Myalgia

11

5 (45.5)

Orientation—yes or no

1

1 (100.0)

Pain

18

7 (38.9)

Paralysis

5

0

Paraesthesia

11

5 (45.5)

Physical—drooling

1

1 (100.0)

Sitting

18

5 (27.8)

Sleep disorder—hypersomnia

4

4 (100.0)

Sleep disorder—hyposomnia

3

2 (66.7)

Stiffness

19

10 (52.6)

Tingling

7

3 (42.9)

Tinnitus

3

3 (100.0)

Vision—blurring

11

3 (27.3)

  1. BPG best possible grade